Bioinformatics Market worth $16.18 Billion by 2021


Posted August 31, 2018 by akshayjadhav

Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics)

 
The global bioinformatics market is projected to reach USD 16.18 Billion by 2021 from USD 6.21 Billion in 2016, growing at a CAGR of 21.1% during the forecast period.

Growth of the bioinformatics market is driven by the growing demand for nucleic acid and protein sequencing, increasing initiatives from government and private organizations, growing application of bioinformatics, and improved collaborative ties between companies and research institutes. It is expected that the market will offer opportunities for manufacturers of bioinformatics solutions with the introduction and adoption of upcoming technologies such as nanopore sequencing and cloud computing. However, factors such as dearth of skilled personnel to ensure proper use of bioinformatics tools and lack of integration of a wide variety of data generated through various bioinformatics platforms are retraining the growth of the market.

The bioinformatics market is segmented on the basis of sector, products and services, application, and region. Based on sector, the market is segmented into medical biotechnology, academics, animal biotechnology, environmental biotechnology, forensic biotechnology, and other sectors (homeland security and defense, law enforcement groups, bioweapon creation, and evolutionary biotechnology). Based on products and services, the bioinformatics market is divided into knowledge management tools, bioinformatics platforms, and bioinformatics services.

Based on application, the bioinformatics market is segmented into genomics, chemoinformatics and drug design, proteomics, transcriptomics, metabolomics, molecular phylogenetics, and other applications (glycomics, cytomics, physiomics, and interactomics). The genomics segment is expected to account for the largest market share in 2016. The large share of this segment can be attributed to the increasing use of pharmacogenomics is a major factor contributing to the growth of this segment.

North America is expected to account for the largest share of the bioinformatics market in 2016. The increasing demand for bioinformatics across genomics and proteomics research, technological advancements, increasing research funding, and presence of a large number of market players and research institutes are driving the growth of the bioinformatics market in this region. However, the Asia-Pacific region is estimated to witness the highest growth during the forecast period.

Get Free Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=39

Factors such as lack of well–defined standards and common data formats for integration of data and lack of user-friendly tools are restraining the growth of the bioinformatics market. Major players operating in the bioinformatics market include Illumina Inc. (U.S.), Agilent Technologies (U.S.), Thermo Fisher Scientific Inc. (U.S.), and QIAGEN N.V (Netherlands).

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By marketsandmarkets
Website Bioinformatics Market worth $16.18 Billion by 2021
Country United States
Categories Biotech , Health , Medical
Tags bioinformatics market
Last Updated August 31, 2018